Evidence map›Paper›PMID 36713053›Full record

ArticleOpen life sciences2023

Identifying two pathogenic variants in a patient with pigmented paravenous retinochoroidal atrophy.

Zeyuan Liu, He Wang, Xiaoli He, Dan Tao, Li Li

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Open life sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 5 citations in OpenAlex.

  1. Pooled it
  2. Observational
  3. Pigmented paravenous chorioretinal atrophy: Updated scenario.European journal of ophthalmology · 2024
    Review
  4. The Structural Abnormalities Are Deeply Involved in the Cause ofInternational journal of molecular sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Zeyuan LiuDepartment of Ophthalmology, Kunming Children's Hospital, No. 288, Qianxing Road, Xishan District, Kunming 650228, China.
He WangDepartment of Ophthalmology, Kunming Children's Hospital, No. 288, Qianxing Road, Xishan District, Kunming 650228, China.
Xiaoli HeDepartment of Ophthalmology, Kunming Children's Hospital, Yunnan Institute of Pediatrics, Yunnan Province Clinical Research Center for Children's Health and Disease, Yunnan Key Laboratory of Children's Major Disease Research, No. 288, Qianxing Road, Xishan District, Kunming 650228, China.
Dan TaoDepartment of Ophthalmology, Kunming Children's Hospital, No. 288, Qianxing Road, Xishan District, Kunming 650228, China.
Li LiDepartment of Ophthalmology, Kunming Children's Hospital, Yunnan Institute of Pediatrics, Yunnan Province Clinical Research Center for Children's Health and Disease, Yunnan Key Laboratory of Children's Major Disease Research, No. 288, Qianxing Road, Xishan District, Kunming 650228, China.
Kunming Children's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Little is known about the genetic background of pigmented paravenous retinochoroidal atrophy (PPRCA) due to rarity of patients. In this study, we identified two pathogenic variants in

Indexed as

pathogenic variantspigmented paravenous retinochoroidal atrophyRPGRIP1whole-exome sequencing

Identifiers

PMID36713053
PMCPMC9843229
OpenAlexW4316468109

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.